Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Radiation Therapy and Myeloid-Derived Suppressor Cells: Breaking Down Their Cancerous Partnership

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.11.050Source: DataRank Database

Radiation Therapy and Myeloid-Derived Suppressor Cells: Breaking Down Their Cancerous Partnership is a research paper published in International Journal of Radiation Oncology*Biology*Physics (2023). On theSindex it has a DataRank of 0.574. It has been cited 45 times.

N/A

0.574DataRank · unranked

Scored on demand from live citation data

Open Access45 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 4.17)OA: hybridTopics (28)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.574

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (10)

Matthew Berkseth,Drew M. Pardoll ORCID,Sudipto Ganguly ORCID,Lawrence Kleinberg ORCID,Jessica Lawrence ORCID

Live enrichment

PubMed:38042450 PMC:PMC11082936 OpenAlex:https://openalex.org/W4389163081

NCI NIH HHS

Grant: U54 CA268069

NINDS NIH HHS

Grant: P50 NS057531

NCI NIH HHS

Grant: P01 CA254849

NCI NIH HHS

Grant: U54 CA210190

FWCI

4.17

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.ijrobp.2023.11.050

publisherhttps://doi.org/10.1016/j.ijrobp.2023.11.050

publisherhttps://api.elsevier.com/content/article/PII:S0360301623081749?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0360301623081749?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38042450

Fields of Study

Immune cells in cancerInflammation biomarkers and pathwaysHistone Deacetylase Inhibitors ResearchHumansMyeloid-Derived Suppressor CellsVascular Endothelial Growth Factor ANeoplasmsTumor MicroenvironmentImmunosuppressive AgentsHypoxia

MeSH Terms

Myeloid-Derived Suppressor CellsHypoxiaHumansImmunosuppressive AgentsNeoplasmsVascular Endothelial Growth Factor ATumor Microenvironment

Keywords

SuppressorCancer researchGeneral partnershipMedicineRadiation therapyMyeloidMyeloid-derived Suppressor CellOncologyCancerInternal medicineBusiness

Sustainable Development Goals

SDG 0: Partnerships for the goals